EP2736536A4 - ISLET CELLS ON MATRIX AND SMALL ISLAND CELL AGGREGATES FOR THE TREATMENT OF DIABETES - Google Patents

ISLET CELLS ON MATRIX AND SMALL ISLAND CELL AGGREGATES FOR THE TREATMENT OF DIABETES

Info

Publication number
EP2736536A4
EP2736536A4 EP12818108.8A EP12818108A EP2736536A4 EP 2736536 A4 EP2736536 A4 EP 2736536A4 EP 12818108 A EP12818108 A EP 12818108A EP 2736536 A4 EP2736536 A4 EP 2736536A4
Authority
EP
European Patent Office
Prior art keywords
diabetes
matrix
treatment
islet cells
cell aggregates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP12818108.8A
Other languages
German (de)
French (fr)
Other versions
EP2736536A2 (en
Inventor
Lisa A Stehno-Bittel
Karthik Ramachandran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kansas
Original Assignee
University of Kansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kansas filed Critical University of Kansas
Priority to EP18186206.1A priority Critical patent/EP3498300A1/en
Publication of EP2736536A2 publication Critical patent/EP2736536A2/en
Publication of EP2736536A4 publication Critical patent/EP2736536A4/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/507—Pancreatic cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/10—Mineral substrates
    • C12N2533/12—Glass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/72—Chitin, chitosan
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2535/00—Supports or coatings for cell culture characterised by topography

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP12818108.8A 2011-07-27 2012-07-26 ISLET CELLS ON MATRIX AND SMALL ISLAND CELL AGGREGATES FOR THE TREATMENT OF DIABETES Ceased EP2736536A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP18186206.1A EP3498300A1 (en) 2011-07-27 2012-07-26 Templated islet cells and small islet cell clusters for diabetes treatment

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161512303P 2011-07-27 2011-07-27
US201213482671A 2012-05-29 2012-05-29
PCT/US2012/048352 WO2013016544A2 (en) 2011-07-27 2012-07-26 Templated islet cells and small islet cell clusters for diabetes treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP18186206.1A Division EP3498300A1 (en) 2011-07-27 2012-07-26 Templated islet cells and small islet cell clusters for diabetes treatment

Publications (2)

Publication Number Publication Date
EP2736536A2 EP2736536A2 (en) 2014-06-04
EP2736536A4 true EP2736536A4 (en) 2015-03-11

Family

ID=46275980

Family Applications (2)

Application Number Title Priority Date Filing Date
EP18186206.1A Withdrawn EP3498300A1 (en) 2011-07-27 2012-07-26 Templated islet cells and small islet cell clusters for diabetes treatment
EP12818108.8A Ceased EP2736536A4 (en) 2011-07-27 2012-07-26 ISLET CELLS ON MATRIX AND SMALL ISLAND CELL AGGREGATES FOR THE TREATMENT OF DIABETES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP18186206.1A Withdrawn EP3498300A1 (en) 2011-07-27 2012-07-26 Templated islet cells and small islet cell clusters for diabetes treatment

Country Status (4)

Country Link
EP (2) EP3498300A1 (en)
JP (1) JP2014521335A (en)
CA (1) CA2842695C (en)
WO (1) WO2013016544A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201906304TA (en) 2013-03-15 2019-08-27 Miromatrix Medical Inc Use of perfusion decellularized liver for islet cell recellularization
JP6405752B2 (en) * 2014-07-01 2018-10-17 大日本印刷株式会社 Cell culture vessel
WO2019241499A1 (en) 2018-06-13 2019-12-19 Miromatrix Medical Inc. Fistula filler and deployment system
DE102019217466A1 (en) * 2019-11-12 2021-05-12 Lpkf Laser & Electronics Ag Glass reaction vessels, manufacturing processes and methods for analysis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007087402A2 (en) * 2006-01-24 2007-08-02 Brown University Cell aggregation and encapsulation device and method
EP2286822A1 (en) * 2009-08-17 2011-02-23 Universiteit Twente Diabetes treatment
WO2011126921A2 (en) * 2010-04-06 2011-10-13 University Of Kansas Templated islet cells and small islet cell clusters for diabetes treatment

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK402984D0 (en) 1984-08-23 1984-08-23 Nordisk Insulinlab PROCEDURE FOR PROMOTING INSULIN-PRODUCING CELLS
EP0363125A3 (en) 1988-10-03 1990-08-16 Hana Biologics Inc. Proliferated pancreatic endocrine cell product and process
US5164000A (en) 1991-06-27 1992-11-17 Gamblin Rodger L Lithographic printing fountain solution
US5280038A (en) 1992-03-13 1994-01-18 Virginia Commonwealth University Histidine as a protective agent in cardiac surgery and myocardial ischemic syndrome
US5696109A (en) 1992-12-07 1997-12-09 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US6703017B1 (en) 1994-04-28 2004-03-09 Ixion Biotechnology, Inc. Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
US5670545A (en) 1996-02-09 1997-09-23 Board Of Regents Of The University Of Colorado Method for the treatment of ischemic disease and reperfusion injury and the prevention of the adverse effects of reactive oxygen species
US6783954B2 (en) 1999-03-05 2004-08-31 Compugen Ltd. VEGF nucleic acid and amino acid sequences
US6103255A (en) * 1999-04-16 2000-08-15 Rutgers, The State University Porous polymer scaffolds for tissue engineering
US20070122904A1 (en) * 2000-09-29 2007-05-31 Unisearch Limited Method and apparatus for culturing cells
US7786257B2 (en) 2000-12-18 2010-08-31 University Of Kansas Signal-1/signal-2 bifunctional peptide inhibitors
US8663626B2 (en) * 2007-03-12 2014-03-04 Technion Research & Development Foundation Limited Vascularized islets and methods of producing same
KR20100121499A (en) * 2008-02-06 2010-11-17 고리츠다이가쿠호진 요코하마시리츠다이가쿠 Cell culture method and screening method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007087402A2 (en) * 2006-01-24 2007-08-02 Brown University Cell aggregation and encapsulation device and method
EP2286822A1 (en) * 2009-08-17 2011-02-23 Universiteit Twente Diabetes treatment
WO2011126921A2 (en) * 2010-04-06 2011-10-13 University Of Kansas Templated islet cells and small islet cell clusters for diabetes treatment

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ALDERT H. PIERSMA: "Alternative Methods for Developmental Toxicity Testing", BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, vol. 98, no. 5, 1 May 2006 (2006-05-01), pages 427 - 431, XP055164713, ISSN: 1742-7835, DOI: 10.1111/j.1742-7843.2006.pto_373.x *
CHOI Y Y ET AL: "Controlled-size embryoid body formation in concave microwell arrays", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 31, no. 15, 1 May 2010 (2010-05-01), pages 4296 - 4303, XP026971506, ISSN: 0142-9612, [retrieved on 20100305] *
HWANG JIN WOOK ET AL: "Optimal size control of pancreatic islet cell clusters using concave-bottomed microwells.", JOURNAL OF CONTROLLED RELEASE : OFFICIAL JOURNAL OF THE CONTROLLED RELEASE SOCIETY 30 NOV 2011, vol. 152 Suppl 1, 30 November 2011 (2011-11-30), pages e218 - e219, XP002734971, ISSN: 1873-4995 *
JIN WOOK HWANG ET AL: "Functional clustering of pancreatic islet cells using concave microwell array", MACROMOLECULAR RESEARCH, vol. 19, no. 12, 3 November 2011 (2011-11-03), pages 1320 - 1326, XP055164708, ISSN: 1598-5032, DOI: 10.1007/s13233-012-1202-4 *
KARTHIK RAMACHANDRAN ET AL: "Engineering Islets for Improved Performance by Optimized Reaggregation in a Micromold", TISSUE ENGINEERING PART A, vol. 19, no. 5-6, 1 March 2013 (2013-03-01), pages 604 - 612, XP055164716, ISSN: 1937-3341, DOI: 10.1089/ten.tea.2012.0553 *
KUNZ-SCHUGHART L A ET AL: "The use of 3-D cultures for high-throughput screening: The multicellular spheroid model", JOURNAL OF BIOMOLECULAR SCREENING, SAGE; LIEBERT, US, vol. 9, no. 4, 1 June 2004 (2004-06-01), pages 273 - 285, XP002694233, ISSN: 1087-0571, DOI: 10.1177/1087057104265040 *

Also Published As

Publication number Publication date
WO2013016544A2 (en) 2013-01-31
WO2013016544A3 (en) 2013-04-25
EP3498300A1 (en) 2019-06-19
EP2736536A2 (en) 2014-06-04
JP2014521335A (en) 2014-08-28
WO2013016544A4 (en) 2013-06-13
CA2842695C (en) 2021-01-12
CA2842695A1 (en) 2013-01-31

Similar Documents

Publication Publication Date Title
EP2794857A4 (en) DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS IN POSITIVE CELLS FOR INDIVIDUAL HORMONAL INSULIN
EP2539763A4 (en) CONTACT LENSES FOR MYOPES AND METHODS FOR TREATING MYOPIA
EP2785359A4 (en) MESENCHYMAL STROMAL CELLS AND USE THEREFOR
EP2262364A4 (en) OXADIAZOANTHRACENES FOR THE TREATMENT OF DIABETES
EP2427928A4 (en) ELECTRODE COMPRISING NANOSTRUCTURES FOR RECHARGEABLE CELLS
EP2510086A4 (en) ENHANCED CELL CULTURE METHODS FOR ADOPTIVE CELL THERAPY
EP2882846A4 (en) METHODS AND COMPOSITIONS FOR THE RAPID PRODUCTION OF RETINE PIGMENTED EPITHELIAL CELLS FROM MULTIPOTENT CELLS
IL215467A (en) Therapeutic Causes for the Treatment of Diseases Associated with Undesirable Rapid Culture of Cells
EP2464219A4 (en) MULTI-TRANSGENIC PIGS FOR THE TREATMENT OF DIABETES
SI2494039T1 (en) The process of reprogramming cells and their use
EP2736437A4 (en) PROCESS AND COMPOSITION FOR THE HYPERTHERMAL TREATMENT OF CELLS
EP2617037A4 (en) STRUCTURES AND METHODS FOR SPIN MOMENT TRANSFER MEMORY CELLS
EP2767527A4 (en) METHOD FOR MANUFACTURING CERAMIC BEES NICKEL STRUCTURE AND CERAMIC BEES NUT STRUCTURE
EP2566566A4 (en) ADULT STEM CELLS / PROGENITOR CELLS AND STEM CELL PROTEINS FOR TREATING OCULAR DISEASES AND INJURIES
EP2563406A4 (en) METHODS, COMPOSITIONS AND KITS FOR THE TREATMENT OF MINERALIZATION DISORDERS OF THE MATRIX
EP2863910A4 (en) COMPOSITIONS AND METHODS FOR REGULATING THE HOMEMYSTASIS OF GLUCOSE AND THE ACTION OF INSULIN
EP2322147A4 (en) USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES OF MICROPARTICLES CONTAINING GENETICALLY MODIFIED CELLS
EP2421888A4 (en) NOVEL CELL AND THERAPEUTIC AND DIAGNOSTIC METHODS BASED ON THE SAME
EP2800579A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF DIABETES
EP2365947A4 (en) TREATMENT OF FLY ASH FOR USE IN CONCRETE
EP2767528A4 (en) METHOD FOR MANUFACTURING CERAMIC BEES NICKEL STRUCTURE AND CERAMIC BEES NUT STRUCTURE
EP2875145A4 (en) METHOD FOR CONSTRUCTING INDICES OF DIVERSITY AND VIABILITY OF MICROORGANISMS IN PROCESS SAMPLES
EP2892541A4 (en) USE OF A DECELLULARIZED EXTRACELLULAR MATRIX FOR ENCAPSULATION OF CELLS
EP2919759A4 (en) MATERIALS AND METHODS USEFUL FOR THE TREATMENT OF GLIOBLASTOMA
EP2736536A4 (en) ISLET CELLS ON MATRIX AND SMALL ISLAND CELL AGGREGATES FOR THE TREATMENT OF DIABETES

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140227

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/00 20060101ALI20150129BHEP

Ipc: A61K 9/16 20060101ALI20150129BHEP

Ipc: A61K 47/48 20060101AFI20150129BHEP

Ipc: A61K 47/30 20060101ALI20150129BHEP

Ipc: C12N 5/071 20100101ALI20150129BHEP

Ipc: A61P 3/10 20060101ALI20150129BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20150210

17Q First examination report despatched

Effective date: 20160614

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

18R Application refused

Effective date: 20180611